We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 83

Opportunities for health industry following 21st Century Cures initiative launch
  • Faegre Baker Daniels LLP
  • USA
  • May 1 2014

On April 30, 2014, House Energy and Commerce Committee Chairman Fred Upton (R-MI) and Committee Member Diana DeGette (D-CO) announced the launch of


Bipartisan voluntary GMO labeling bill introduced in U.S. House
  • Faegre Baker Daniels LLP
  • USA
  • April 16 2014

On April 9, 2014, Reps. Mike Pompeo (R-KS) and G.K. Butterfield (D-NC) filed legislation that would create a voluntary system for labeling food


OPDP did not “like” that postuntitled letter follows
  • Faegre Baker Daniels LLP
  • USA
  • March 19 2014

Recently FDA's Office of Prescription Drug Promotion (OPDP) published an untitled letter issued to Institut Biochimique SA for this Facebook post. As


D.C. Court of Appeals upholds FDA jurisdiction in Regenerative Sciences
  • Faegre Baker Daniels LLP
  • USA
  • February 10 2014

Last week, the D.C. Court of Appeals upheld the FDA's District Court victory in United States v. Regenerative Sciences, LLC, No. 12-5254. The


FDA holds public meeting on FSMA animal feed rule
  • Faegre Baker Daniels LLP
  • USA
  • November 27 2013

The Food and Drug Administration (FDA) conducted a public meeting on November 21, 2013, to discuss the Proposed Rule to Establish Current Good


FDA takes steps to remove GRAS status for trans fats, seeks comments
  • Faegre Baker Daniels LLP
  • USA
  • November 7 2013

Today the Food and Drug Administration (FDA) announced that it will take steps to further reduce trans fats in processed foods, in what Commissioner


Comments invited on FDA's proposed rules for animal foodfeed manufacturing practices
  • Faegre Baker Daniels LLP
  • USA
  • October 28 2013

Last Friday, the U.S. Food and Drug Administration (FDA) announced the release of a long-awaited proposed rule required by Section 103 of the Food


What reopening of the government means for medical device stakeholders
  • Faegre Baker Daniels LLP
  • USA
  • October 18 2013

Business is back to normal or close to normal for the Food and Drug Administration's Center for Devices and Radiological Health


Effects of government shutdown and Farm Bill expiration on food and agriculture industry
  • Faegre Baker Daniels LLP
  • USA
  • October 7 2013

The shutdown of the federal government for the first time since 1996, initiated at 12:00 a.m. On Tuesday, October 1, 2013, by the expiration of FY


FDA holds public meeting on FSMA import safety rules
  • Faegre Baker Daniels LLP
  • USA
  • October 7 2013

On September 19-20, 2013, the U.S. Food and Drug Administration (FDA) conducted a public meeting on Proposed Rules published in July to implement